Mainz, Germany

Tiffnay Kay McIntire

This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tiffnay Kay McIntire. Retrieved from https://idiyas.com/inventor/tiffnay-kay-mcintire

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tiffnay Kay McIntire: Innovator in Drug Delivery Technology

Introduction

Tiffnay Kay McIntire is a notable inventor based in Mainz, Germany. He has made significant contributions to the field of drug delivery technology. With a focus on innovative solutions, McIntire has developed a patent that enhances the efficiency of drug administration.

Latest Patents

McIntire holds a patent for a drug delivery device. This invention aims to improve the way medications are delivered to patients, ensuring better efficacy and patient compliance. His work in this area has the potential to revolutionize treatment protocols in various medical fields.

Career Highlights

Currently, Tiffnay Kay McIntire is employed at Eli Lilly and Company. His role at this prestigious pharmaceutical company allows him to work on cutting-edge research and development projects. McIntire's expertise in drug delivery systems has positioned him as a valuable asset in the industry.

Collaborations

Throughout his career, McIntire has collaborated with several talented individuals, including Mark Lafever and Grant Andrew Walker. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Tiffnay Kay McIntire is a prominent figure in the realm of drug delivery technology. His patent and work at Eli Lilly and Company highlight his commitment to advancing medical solutions. Through collaboration and innovation, McIntire continues to make a significant impact in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…